CC
ETON icon

Cannell Capital’s Eton Pharmaceutcials ETON Stock Holding History

Cannell Capital’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.18M Sell
170,747
-171,238
-50% -$5.02M 4.14% 11
2026
Q1 		$8.44M Buy
341,985
+125,068
+58% +$2.19M 5.18% 5
2025
Q4 		$3.67M Sell
216,917
-238,488
-52% -$4.2M 1.78% 22
2025
Q3 		$9.9M Buy
455,405
+67,230
+17% +$1.12M 1.51% 12
2025
Q2 		$5.53M Sell
388,175
-303,192
-44% -$4.79M 1.65% 24
2025
Q1 		$8.97M Buy
691,367
+310,044
+81% +$4.68M 2.99% 12
2024
Q4 		$5.08M Buy
+381,323
New +$3.87M 1.04% 28

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Cannell Capital's ETON Position: Q2 2026 in Review

Cannell Capital reduced its Eton Pharmaceutcials (ETON) stake by 50% in Q2 2026, selling an estimated $5.02M and leaving 170,747 shares worth $6.18M. The position accounts for 4.14% of the portfolio, ranked #11.

Cannell Capital first reported a position in ETON in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.9M in Q3 2025. 165 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Cannell Capital held 170,747 shares of Eton Pharmaceutcials worth $6.18M as of Q2 2026.
  • Cannell Capital sold 171,238 Eton Pharmaceutcials shares in Q2 2026, an estimated $5.02M.
  • Eton Pharmaceutcials made up 4.14% of Cannell Capital's portfolio in Q2 2026, its #11 holding.
  • Cannell Capital first reported a position in Eton Pharmaceutcials in Q4 2024 and has held it in 7 quarters since.
  • Cannell Capital's Eton Pharmaceutcials position peaked at $9.9M in Q3 2025.
  • 165 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Cannell Capital's 13F filing for Q2 2026, filed 18 Aug 2026.